Analystreport

Avid Bioservices Inc (NASDAQ: CDMO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.

Avid Bioservices, Inc.  (CDMO) 
Last avid bioservices, inc. earnings: 3/10 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.avidbio.com